Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Universita Vita-Salute San Raffaele |
| Country | Italy |
| Start Date | Jan 01, 2025 |
| End Date | Dec 31, 2029 |
| Duration | 1,825 days |
| Number of Grantees | 2 |
| Roles | Third Party; Coordinator |
| Data Source | European Commission |
| Grant ID | 101163219 |
Understanding what makes our cells prone to develop cancer is key for identifying effective strategies of tumor prevention.
By analyzing the genome of normal human cells, I obtained compelling evidence that the pattern of somatic mutations can be used to identify the cell-of-origin of kidney cancer.
Although every cell accumulates somatic mutations during a lifetime, some are exposed to a specific mutational process that leave a detectable mark in their genome.
Kidney cancers and their cell-of-origin show the same genetic mark, consisting of excess somatic point mutations with unique characteristics and unknown origin.
We plan to use this mutational signature to track cancer-prone cells in human kidneys and a) follow their population dynamics; b) study their genome and transcriptome at a single cell level; c) understand the underlying causes of excessive mutation.
Having already established a non-invasive assay to detect cancer-prone cells in urine samples, we can now analyse numerous donors, longitudinally and without biopsies.
Our preliminary analyses point to adaptation to low-oxygen conditions (hypoxia) as the likely cause of excessive mutation in kidney cells and suggest defects in specific DNA repair pathways as a mechanism.
We will test whether overactivation of hypoxia signalling, caused by either a genetic syndrome or exposure to renal ischemia, induces the kidney-specific mutational signature in humans. We will then dissect the molecular mechanism by functional experiments in vitro and in mouse models.
Finally, we will test whether and how the diet contributes to the expansion of the mutation-prone cell subset in mouse kidneys.
Overall, this study will provide unprecedented resolution of early events leading to kidney cancer initiation and will determine whether hypoxic stress is mutagenic and cancer-promoting.
Further, this project will pursue the novel idea that cells can be tracked and possibly arrested before cancer initiation.
Ospedale San Raffaele Srl; Universita Vita-Salute San Raffaele
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant